Abstract:Immune cell-derived extracellular vesicles (EVs) have increasingly become the focus of research due to their unique characteristics and bioinspired applications. They are lipid bilayer membrane nanosized vesicles harboring a range of immune cell-derived surface receptors and effector molecules from parental cells. Immune cell-derived EVs are important mediators of intercellular communication that regulate specific mechanisms of adaptive and innate immune responses. However, the mechanisms underlying the antitumor effects of EVs are still being explored. Importantly, immune cell-derived EVs have some unique features, including accessibility, storage, ability to pass through blood-brain and blood-tumor barriers, and loading of various effector molecules. Immune cell-derived EVs have been directly applied or engineered as potent antitumor vaccines or for the diagnosis of clinical diseases. More research applications involving genetic engineering, membrane engineering, and cargo delivery strategies have improved the treatment efficacy of EVs. Immune cell-derived EV-based therapies are expected to become a separate technique or to complement immunotherapy, radiotherapy, chemotherapy and other therapeutic modalities. This review aims to provide a comprehensive overview of the characteristics and functions of immune cell-derived EVs derived from adaptive (CD4 + T, CD8 + T and B cells) and innate immune cells (macrophages, NK cells, DCs, and neutrophils) and discuss emerging therapeutic opportunities and prospects in cancer treatment.

Anticancer Therapy Targeting Cancer-Derived Extracellular Vesicles

Extracellular vesicles derived from immune cells: Role in tumor therapy

Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy

Engineered Extracellular Vesicles for Cancer Therapy

Extracellular Vesicles in Cancer Metastasis: Potential as Therapeutic Targets and Materials

Extracellular vesicles for cancer therapy: potential, progress, and clinical challenges

Advances and challenges in clinical applications of tumor cell-derived extracellular vesicles

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy

Extracellular Vesicles for Drug Delivery in Cancer Treatment

The Biology and Function of Extracellular Vesicles in Cancer Development

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Harnessing the therapeutic potential of extracellular vesicles for cancer treatment

Extracellular Vesicles in Cancer: Golden Goose or Trojan Horse.

New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies

The Roles of Extracellular Vesicles in Malignant Melanoma

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation